Kronilog Tablet contains Alpha Ketoanalogue (NA), a specialized compound used primarily as a nutritional supplement in the management of chronic kidney disease (CKD). Alpha Ketoanalogue serves as a nitrogen-free analogue of essential amino acids, designed to provide the necessary substrates for protein synthesis while minimizing nitrogenous waste production. This mechanism aids in reducing the accumulation of uremic toxins, thereby alleviating symptoms associated with renal insufficiency and slowing the progression of renal impairment. Kronilog is typically administered alongside a controlled low-protein diet to optimize metabolic balance and maintain nutritional status in patients with compromised kidney function. The tablet formulation ensures precise dosing and improved patient compliance. Clinical use of Kronilog has demonstrated benefits in delaying the need for dialysis and improving overall quality of life in CKD patients. It is important to use this medication under strict medical supervision, with regular monitoring of renal function and nutritional parameters. Adverse effects are generally minimal but may include gastrointestinal disturbances or hypersensitivity reactions. Kronilog should be avoided in patients with known hypersensitivity to its components and used cautiously in those with hepatic impairment. This product is an essential adjunct in the multidisciplinary approach to managing chronic kidney disease.